Outcome of patients with arthritis and parvovirus B19 DNA in synovial membranes

Rheumatology International

Volumn 27, Issue 8, 2007, Pages 747-751

  Schmid, Simone ^a   Bossart, Walter ^b   Michel, Beat A ^a   Brühlmann, Pius ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Arthritis; Needlearthroscopy; Parvovirus B19; Synovial membrane

Indexed keywords

ANTIBIOTIC AGENT; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; VIRUS DNA;

ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; ARTHRITIS; ARTHROSCOPY; ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE COURSE; ENTAMOEBA HISTOLYTICA; FECES ANALYSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL INFECTION; HUMAN; JOINT BIOPSY; JOINT EFFUSION; KNEE; LYME DISEASE; MALE; OBSERVATIONAL STUDY; PARVOVIRUS; PATIENT ASSESSMENT; POLYARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; REMISSION; RHEUMATOID ARTHRITIS; SALMONELLA TYPHIMURIUM; SYNOVIAL FLUID; SYNOVIUM;

ADULT; ARTHRITIS; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE;

EID: 34248225002     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0337-2     Document Type: Article

References (27)

1. Schirmer M, Fischer M, Rossboth DW, Mur E, Dierich MP, Frischhut B (1998) Entamoeba hartmanni: a new causative agent in the pathogenesis of reactive arthritis? Rheumatol Int 18:37-38
2. Kasliwal RM (1981) Chronic colitis and arthritis with special emphasis on amoebic colitis. Am J Proctol Gastroenterol Colon Rectal Surg 32:12, 16, 28
3. Haslock I, Wright V (1974) Arthritis and intestinal disease. J R Coll Phys Lond 8:154-162
4. Than-Saw, Mar-Mar-Nyein, Oo MM et al (1992) Isolation of Entamoeba histolytica from arthritic knee joint. Trop Geogr Med 44:355-358
5. Modrow S (2001) Parvovirus B19: Ein Infektionserreger mit vielen Erkrankungensbildern. Dtsch Arztebl 98:A1620-1624
6. Stoll T, Bruhlmann P, Brunner U, Treier A, Cassinotti P, Michel BA (1995) Parvovirus-B19-induced arthritis/arthropathy-an important differential diagnosis of chronic polyarthritis. Schweiz Med Wochenschr 125:347-354
7. Soderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K (1997) Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 349:1063-1065
8. Speyer I, Breedveld FC, Dijkmans BA (1998) Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients Clin Exp Rheumatol 16:576-578
9. Saal JG, Steidle M, Einsele H, Muller CA, Fritz P, Zacher J (1992) Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 12:147-151
10. Kerr LR, Cartron JP, Curran MD, Moore JE, Elliot JR, Mollan RA (1995) A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 34:809-813
11. Foto F, Saag KG, Scharosch LL, Howard EJ, Naides SJ (1993) Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis 167:744-748
12. Cassinotti P, Siegl G, Michel BA, Bruhlmann P (1998) Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin. J Med Virol 56:199-204
13. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M (2001) A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 92:183-191
14. Smith PF (1996) Third international conference on harmonization of technical requirements for the registration of pharmaceuticals for human use-a toxicologist's perspective. Toxicol Pathol 24:519-528
15. Guidelines of the Council of Europe (1999) PA/PH/OMCL (98) 22, DEF
16. Kasliwal RM (1973) Clinical amoebiasis syndrome and case reports of a few unusual cases of amoebiasis. Am J Proctol 24:326-332
17. Woolf AD, Campion GV, Chishick A et al (1989) Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 149:1153-1156
18. Naides SJ, Field EH (1988) Transient rheumatoid factor positivity in acute human parvovirus B19 infection. Arch Intern Med 148:2587-2589
19. Anderson LJ (1990) Human parvovirus B19. Pediatr Ann 19:509-10, 512-513
20. Clewley JP (1989) Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 27:2647-2651
21. Kerr JR, Cunniffe VS (2000) Antibodies to parvovirus B19 nonstructural protein are associated with chronic but not acute arthritis following B19 infection. Rheumatology (Oxford) 39:903-908
22. Naides SJ (1998) Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 24:375-401
23. Cohen BJ, Buckley MM, Clewley JP, Jones VE, Puttick AH, Jacoby RK (1986) Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann Rheum Dis 45:832-838
24. Tyndall A, Jelk W, Hirsch HH (1994) Parvovirus B19 and erosive polyarthritis. Lancet 343:480-481
25. Nikkari S, Roivainen A, Hannonen P et al (1995) Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 54:597-600
26. Takahashi Y, Murai C, Shibata S et al (1998) Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 95:8227-8232
27. Naides SJ, Scharosch LL, Foto F, Howard EJ (1990) Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum 33:1297-1309